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Fecal egg count reduction test
Horses in Iceland have been isolated for more than 1,000 yr but still harbor a similar range of
gastrointestinal parasites as do horses across the world. The long isolation of the horses and their
parasites presumably means that no resistance genes have been introduced into the Parascaris spp.
population. It is therefore of particular interest to investigate the efficacy of ivermectin on Parascaris
spp. infecting Icelandic foals. Potential treatment failure of ivermectin in Iceland will add substantial
new information on how resistance can arise independently. This study aimed to determine the
efficacy of subcutaneous injection of ivermectin for the treatment of Parascaris spp. infection in foals
and to identify the Parascaris species present in the west and north of Iceland. A fecal egg count
reduction (FECR) test (FECRT) was performed on 50 foals from 8 farms, including an untreated
control group of 6 foals, from September to November 2019. The foals were between 3 and 5 mo of
age at the start of the study and had not previously been treated with anthelmintic drugs. Each foal
was treated subcutaneously with off-label use of Ivomect injection 10 mg/ml or Noromectint 1% at
a dose of 0.2 mg/kg. The FECR for each farm was calculated in 2 ways, by the eggCounts package in
R and by the Presidente formula (FECRT). Both calculation methods resulted in efficacy levels
between 0% and 80.78%, indicating ivermectin resistance on all farms. We also confirmed, by
karyotyping, that the species of equine ascarid present in the west and north of Iceland is Parascaris
univalens. This study provides evidence for treatment failure of ivermectin against P. univalens
infection in foals. Since Icelandic horses have been isolated on the island for more than 1,000 yr, this
implies that resistance alleles have developed independently in the Icelandic Parascaris population.
The actual clinical impact of ivermectin resistance is unknown but another drug of choice should be
considered to treat Parascaris infection in foals in Iceland.
The Icelandic horse is the only breed of horse in Iceland. The
horse population was introduced by settlers in the ninth and 10th
centuries and has been isolated for approximately 1,000 yr
(Adalsteinsson, 1981). Despite the isolation, Icelandic horses have
been found to harbor a similar diversity of equine gastrointestinal
helminths commonly infecting horses in other countries of similar
climates, such as small and large strongyles, ascarids, and cestodes
(Eydal, 1983).
Equine nematodes in the family Ascarididae, Parascaris spp.
are pathogenic parasites of foals and yearlings worldwide and
are also commonly found in foals in Iceland (Eydal, 1983). The
genus Parascaris contains 2 species, Parascaris equorum, and
Parascaris univalens, which are morphologically identical but
can be distinguished by karyotyping, as P. equorum has 2 pairs
of chromosomes and P. univalens has 1 pair (Goday and
Pimpinelli, 1986). Recent studies from North America and
Europe have shown that P. univalens is the dominating species
infecting horses (Jabbar et al., 2014; Nielsen et al., 2014; Martin
et al., 2018).
Clinical signs of Parascaris spp. infection such as nasal
discharge and coughing may be observed during the larval
migration. The adult parasites present in the small intestine may
cause weight loss and impaired growth, whereas large burdens can
lead to obstruction and perforation of the intestine (Cribb et al.,
2006). Parascaris eggs are shed in the foals’ feces and can stay
infective for several years, generating a high infection pressure on
stud farms with many foals (Lindgren et al., 2008). Because of the
potential severity of the infection, most foals are dewormed
several times during their first year (ESCCAP, 2019).
Overuse of anthelmintic drugs has led to the development of
anthelmintic resistance in several parasites of veterinary impor-
tance (Reinemeyer, 2009). In 2002 the first case of Parascaris spp.
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resistance to the anthelmintic drug ivermectin was reported from
the Netherlands (Boersema et al., 2002), followed by reports from
other European countries (Stoneham and Coles, 2006; Schou-
gaard and Nielsen, 2007; von Samson-Himmelstjerna et al., 2007;
Lindgren et al., 2008), North America (Lyons et al., 2008), and
Australia (Armstrong et al., 2014). Reports also show treatment
failure of pyrantel in North America, Europe, and Australia
(Lyons et al., 2008; Armstrong et al., 2014; Martin et al., 2018)
and, more recently, of fenbendazole in Australia and Saudi
Arabia (Armstrong et al., 2014; Alanazi et al., 2017).
In Iceland, mares and young horses are usually kept outside
throughout the year and have access to large areas of uncultivated
land for grazing, which would presumably reduce the infection
pressure of parasites. Many breeding farms leave the foals
relatively unhandled, allowing them to roam the highlands with
the herd during their first summer. Therefore the off-label use of
subcutaneous-injection ivermectin (such as Ivomect vet 10 mg/ml
and Noromectint 1%) is preferred as an antiparasitic treatment
rather than oral paste formulations registered for horses (Paulrud
et al., 1997). The efficacy of both parenterally and orally
administrated ivermectin showed a 100% elimination of adult
Parascaris spp. worms at the recommended dose of 0.2 mg/kg
when the drug was introduced on the market (Campbell et al.,
1989).
The long isolation of the horses and their parasites presumably
means that no resistance genes have been introduced into the
Parascaris spp. population. It is therefore of particular interest to
investigate the efficacy of ivermectin on Parascaris spp. infecting
Icelandic foals. Potential treatment failure of ivermectin in
Iceland will add substantial new information on how resistance
can arise independently. This study aimed to determine the
efficacy of subcutaneous injection of ivermectin for the treatment
of Parascaris spp. infection in foals and to identify the Parascaris
species present in the west and north of Iceland.
MATERIALS AND METHODS
Ethical permission
The study was conducted following the Icelandic Animal Care
Guidelines for experimental animals (the Icelandic Animal
Welfare Act 55/2013) and the Icelandic regulation on the
protection of animals used for scientific purposes 460/2017, and
formally approved by the Icelandic Ethical Committee on Animal
Research, license 2019-04-10.
Farms and horses
The study was performed on farms in the west and north of
Iceland from September to November 2019. A total of 85 foals
from 10 farms was screened for the presence of Parascaris spp.
eggs. Only farms with a minimum of 4 foals excreting 100
Parascaris spp. eggs per gram (EPG) were included in the fecal
egg count reduction test (FECRT). A group of 6 foals from one of
the farms served as a control for normal variation in Parascaris
spp. EPG and was not treated with any anthelmintic drug. All
foals included in the study were between 3 and 5 mo of age at the
start of the study, had not previously been treated with
anthelmintic drugs, and were with their dams throughout the
observation period.
Anthelmintic treatment
Each foal and the corresponding dam (except the control
group) were treated with the recommended dosage (0.2 mg/kg) of
Ivomec vet 10 mg/ml (Boehringer Ingelheim, Ingelheim, Ger-
many) (farms 1, 2, 3, 6, 7, and 8) or Noromectin 1% (Norbrook
Laboratories, Newry, U.K.) (farms 4 and 5). The veterinarian in
charge estimated the weight of the foals to be 150–200 kg and a
dose was calculated for 200-kg body weight, resulting in a
subcutaneous injection of 4 ml for each foal. The dams were
treated with 8 ml of the same drug.
Fecal egg count reduction test
Individual fecal samples were collected from the ground or the
rectum of the foals, placed in plastic bags, and kept cold during
transportation to the laboratory (Institute for Experimental
Pathology at Keldur, University of Iceland, Reykjavı́k, Iceland).
Fecal egg counts (FECs) were performed using a McMaster
technique slightly modified from Roepstorff and Nansen (1998),
where 4 g of feces were suspended in 56 ml of tap water, mixed
thoroughly, and then sieved through a mesh with an aperture of
0.8 mm. The strained fluid was centrifuged for 5 min at 500 g, the
supernatant discarded, and the pellet mixed in FASOLt reagent
(Kruuse, Langeskov, Denmark). Two McMaster chambers were
filled (0.5 ml/chamber) and counted, including the area around
the grid, resulting in a minimum detection limit of 7.5 EPG.
Paired FEC samples were analyzed on day 0 (pretreatment) and
days 11–15 posttreatment. The follow-up samples were collected
from the control group on day 20.
The farm owners answered questions regarding farm size,
pasture management, and deworming routines practiced (Table
I).
Data analysis
The FECRs for each farm were calculated in 2 ways: (1) data
were analyzed in R version 3.6.3 with the eggCounts package
version 2.3 using a Bayesian model for paired design (fecr_stan)
(R Core Team, 2018; Wang and Paul, 2018); (2) FECR was
calculated according to the Presidente formula (Presidente, 1985):
Table I. Questionnaire to farmers.
Information Descriptor
Number of horses on the farm Number
Number of foals Number
Access to separate winter and
summer pasture
Yes/no
Sharing summer pasture with
other farms
Yes/no




horse groups on pasture
Yes, age, gender, other groups/no
Deworming routines applied
on the farm
(1) Only after examination of fecal
samples
(2) Routine deworming once/yr
(3) Routine deworming 2–4 times/yr
Number of treatments and
time of deworming
Number/month
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where Tpre is the pretreatment egg count arithmetic group mean
(AGM) of the treated group, Tpost the posttreatment egg count
AGM of the treated group, and Cpre and Cpost are the pre- and
posttreatment AGMs of the untreated control group. It should be
noted that the control group only contained foals from farm 1.
Results were interpreted according to the guidelines regarding
FECRT of strongyle nematodes issued by the American
Association of Equine Practitioners (Nielsen et al., 2019), as
there are currently no guidelines available for Parascaris spp.
According to these guidelines, the expected efficacy for ivermectin
should be 99.9% and an efficacy below 95% is regarded as
confirmation of resistance.
Karyotyping
To determine the Parascaris species of roundworm present in
west and north Iceland, karyotyping was performed on Parascaris
spp. eggs. Fecal samples for karyotyping were collected from 1
farm in the north and 1 in the west of Iceland. Karyotyping was
performed on approximately 1,000 eggs from each of the 2 farms
as described by Martin et al. (2018).
RESULTS
Fecal egg count reduction test
Eight of 10 farms fulfilled the inclusion criteria with a minimum
of 4 foals/farm excreting 100 Parascaris EPG (Table II). In
total, 44 treated foals and 6 control foals were included in the
FECRT. Among the 44 foals that received treatment, 24 (55%)
had an increase in egg excretion at the second FEC and only 4
(9%) had an egg count of 0 after treatment (Fig. 1).
Calculated FECR using eggCounts package in R for all farms
including the control group are shown in Table III. None of the
investigated farms showed the expected efficacy of the ivermectin
treatment (99.9%). Farms 1, 3, 4, 6, and 8 showed very poor
efficacy, with a reduction of P. univalens eggs of ,6.0%, whereas
a slightly better efficacy with a reduction between 33.64% and
80.78% was noted on farms 2, 5, and 7 (Table III). The results of
decreased efficacy were supported by lower confidence levels of
less than 90% in all cases. The normal variation of egg excretion
displayed by the control group of 6 foals showed a 33.24%
reduction of Parascaris EPG at the second sampling (Table III).
Calculated FECR using the Presidente formula including the
control group in the calculation are displayed in Table III. Overall
the FECRT revealed an even lower efficacy of ivermectin
treatment that is explained by a lower mean FEC of the control
group compared with mean FEC at farms 1, 3, 4, 5, and 8 at the
second sampling and thus resulting in negative reduction values.
Deworming routines practiced on the farms
Deworming routines and parasite management practices used
on the farms are displayed in Table IV. All farmers dewormed
their foals and horses on a routine basis once or twice yearly
without prior parasite diagnostic tests. All farms treated their
foals in the autumn, and at some farms, a second treatment was
added the following spring. All farms had large areas for grazing
and had access to separate summer and winter pastures. Many of
the farms shared summer pastures for mares, foals, and young
horses with other farms in the same region. Three farms applied
mixed grazing with sheep when possible. All farms separated the
horses in different pastures on the basis of age, gender, and use of
the horses.
Karyotype
Karyotypes were successfully obtained from Parascaris eggs. A
single pair of chromosomes was detected in the samples from both
farms, confirming the species to be P. univalens.
DISCUSSION
The main purpose of this study was to investigate the efficacy of
subcutaneous injection of ivermectin of Icelandic foals naturally
infected with P. univalens. The FECR calculated by the
eggCounts package in R (Wang and Paul, 2018) showed
treatment failure of ivermectin on all of the investigated farms,
with efficacy of less than 6% on 5 farms and between 33.64% and
80.78% on the 3 remaining farms. It should be mentioned that the
number of foals in our study was small. In total 85 foals were
screened for Parascaris spp. eggs but of these only 50 individuals
were excreting 100 EPG, which was the inclusion criteria for the
FECRT. Of these 50 individuals, 6 foals from 1 farm were
included in a control group and left untreated. It has recently been
Table II. Descriptive data on farms included in the fecal egg count reduction test.















1 N 7 1-7 4-5 578 6 348 641 6 524 1,290.0 1,725.0
2 N 9 8-16 4-5 1,370 6 705 908 6 500 2,535.0 1,395.0
3 N 4 17-20 4-5 2,987 6 758 3,651 6 4,145 3,735.0 8,182.5
4 N 6 21-26 3-5 478 6 258 738 6 499 810.0 1,582.5
5 N 4 27-30 4 488 6 660 94 6 111 1,477.5 217.5
6 W 4 31-34 3-5 939 6 504 889 6 1,241 1,687.5 2,640.0
7 N 5 35-39 4-5 708 6 443 309 6 341 1,140.0 847.5
8 W 5 40-44 4-5 905 6 407 1,107 6 645 1,575.0 1,942.5
‡ C N 6 45-50 4-5 823 6 685 548 6 556 1,762.5 1,582.5
* N¼ north Iceland, W ¼ west Iceland.
† Pre- and posttreatment egg counts.
‡ C, untreated control foals on farm 1.
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recommended by Morris et al. (2019) to include an untreated
control group for the evaluation of treatment efficacy against
Parascaris spp. to account for natural changes in egg excretion.
However, the mean FEC in our control group was reduced at the
second sampling compared with an increase of mean FEC of the
foals that received treatment on 5 farms. This resulted in an even
lower efficacy of ivermectin treatment using the FECR (Presi-
dente, 1985) compared with when calculated by the eggCounts
package in R. Taken together, both FECR methods reveal poor
treatment efficacy of subcutaneous injection of ivermectin against
P. univalens in Icelandic foals. Even though resistance to
ivermectin in Parascaris spp. is widespread across the world
(Boersema et al., 2002; Lyons et al., 2008; Armstrong et al., 2014;
Cooper et al., 2020), the low efficacy of ivermectin in Iceland was
somewhat surprising since neither farmers nor veterinarians
included in this study have observed any severe clinical signs of
Parascaris spp. infection.
Because of the restriction of the importation of horses into
Iceland since well before the introduction of anthelmintic drugs
on the market, we can assume that no ivermectin resistance alleles
have been imported. According to Doyle and Cotton (2019),
resistance-conferring alleles are believed to arise de novo in a
population and then be selected from a low starting allele
frequency in response to drug treatment. Despite the less intense
use of anthelmintic drugs in Iceland compared with other
countries (Eydal and Gunnarsson, 1994), resistance alleles seem
to have been favored and are now inherited in the P. univalens
population. Since foals from different farms roam the highlands
with their herds during the grazing season, extensive transmission
of resistance alleles between geographically distant farms can
occur. This study shows that the spread of an ivermectin-resistant
phenotype, and thereby most likely resistance alleles, occurs in the
Icelandic P. univalens population.
Foals in Iceland are normally dewormed with a single
treatment in the autumn, in comparison with more intense
recommendations in other countries, with 2–3 deworming
occasions during the first year (ESCCAP, 2019). According to a
simulation model developed by Leathwick et al. (2017), the timing
of a single anthelmintic treatment against Parascaris spp. has
considerable influence on the development of resistance, which
arises more rapidly when foals receive a single treatment at 3–4
mo of age rather than earlier or later. It could thus be speculated
that the single treatment in the autumn, often at the age of 3–4
mo, might have driven the development of resistance since it has
given an advantage to resistant-genotype worms to survive
treatment and continue passing eggs into the environment.
Table III. Parascaris univalens egg reduction on each farm using 2 different
methods of calculating the fecal egg count reduction (FECR).
Farm
FECR %










* FECR calculated by the R-package ‘‘eggCounts’’.
† FECR calculated by the Presidente formula: FECRT¼ 1003 (1 – [Tpost/
Tpre] 3 (Cpre/Cpost]).
‡ C, untreated control foals on farm 1.
Figure 1. Individual pre- (black
bars) and post- (gray bars) treatment
fecal egg counts for Parascaris univa-
lens. Foal numbers 1–44 were treated
by subcutaneous injection of ivermec-
tin, whereas foal numbers 45–50 were
included in an untreated control
group. For information on the farms
to which the individual foals belong,
see Table II.
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In this study we evaluated the efficacy of subcutaneous
injection of ivermectin, since this formula is widely used for off-
label treatment of horses in Iceland rather than the oral paste
(Paulrud et al., 1997). When ivermectin was approved for use in
horses in the 1980s it was initially introduced as a sterile solution
for intramuscular administration, showing a 100% elimination of
adult Parascaris spp. worms and 98.5% elimination of immature
worms at doses of 0.2 and 0.3 mg/kg. However, the parenteral
formula was later withdrawn after association with adverse
reactions such as inflammation and infections with Clostridium
spp. at the injection site (Yazwinski et al., 1982; Campbell et al.,
1989). Several studies have observed that the route of adminis-
tration considerably affects the deposition of ivermectin, where
parenteral administration has a more prolonged availability and
persistent concentration compared with oral administration of
paste (Marriner et al., 1987; Perez et al., 2002; Saumell et al.,
2017). However, Saumell et al. (2017) noted a lower efficacy
against small strongyles after intramuscular injection in compar-
ison with oral paste, suggesting that worms located in the lumen
of the large intestine receive a higher drug concentration after oral
administration. The foals in this study likely received some
additional ivermectin through the oral route since the mares were
treated the same day and macrocyclic lactones are excreted to
some extent in the milk (Campillo et al., 2013; Gokbulut et al.,
2013). Thus, the parenteral administration of ivermectin in this
study should not be the reason for the low efficacy of the drug.
We have also shown that the ascarid species infecting horses in
the northern and western parts of Iceland is P. univalens. This is in
accordance with previous work where P. univalens has been
detected by cytological tests in the USA (Nielsen et al., 2014),
Switzerland (Jabbar et al., 2014), and Sweden (Martin et al.,
2018), as well as the south of Iceland (Martin et al., 2020). Since
the importation of horses has been officially prohibited for more
than 100 yr and there is no evidence of importation since the
settlement of the island, it is likely that P. univalens has been the
major species infecting Icelandic horses for a long time. This is
further supported by a population study based on genetic
mapping of Parascaris spp. from 6 countries, including Iceland,
showing that the global population of Parascaris is genetically
homogenous (Tydén et al., 2016). Taken together, these findings
support the hypothesis that P. univalens is the dominating species
infecting horses worldwide.
In summary, we confirmed that the species of equine ascarids
present in Iceland is P. univalens. This study further provides
evidence for treatment failure of ivermectin against Parascaris
spp. infection in foals. Since Icelandic horses have been isolated
on the island since before the introduction of ivermectin, this
implies that the resistance phenotype has developed independent-
ly in the Icelandic P. univalens population. This population would
therefore be valuable in further studies into the genetic
background of ivermectin resistance. The actual clinical impact
of ivermectin resistance is unknown but another drug of choice
should be considered to treat Parascaris infection in foals in
Iceland.
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